Maynard Um
-
-
-
-
-
-
-
FDA approves Lilly's Jaypirca for first-line CLL/SLL treatment
-
-
-
-
-
-
-
Lilly's EloraTZP shows greater weight loss than tirzepatide in Phase 2b trial
-
-
-
-
-
-
-
Lilly launches access initiative for diabetes drugs in low-income countries
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim
-
-
-
-
-
-
-
Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease
-
-
-
-
-
-
-
Eli Lilly selects Veeva Vault CRM for global deployment
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) call put ratio 1 call to 1.4 puts into quarter results
-
467,383 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


